showed mild irritation / and reflux; stomach pain; stomach pain and burning; chills; sweating; dry heaves; nausea; a sensation that she had to urinate all the time; inability to eat or drink; This case was reported by a consumer via call center representative and described the occurrence of gastric irritation in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included TOZINAMERAN (COVID-19 VACCINE PFIZER) for prophylaxis, acetylsalicylic acid (Aspirin) for product used for unknown indication and naproxen for product used for unknown indication.   The patient's past medical history included esophageal disorder (unknown problem with esophagus and underwent a stomach wrap procedure several years ago.). Previously administered products included Shingrix with an associated reaction of pain in extremity (received 1st dose on an unknown date, refer case US2021131455).   On an unknown date, the patient received the 2nd dose of Shingrix (intramuscular), the 1st dose of COVID-19 VACCINE PFIZER, Aspirin at an unknown dose and frequency and naproxen at an unknown dose and frequency. On an unknown date, less than a week after receiving Shingrix and an unknown time after starting Aspirin, the patient experienced gastric irritation, stomach pain, stomach burning sensation of, chills, sweating, dry heaves, nausea, urinary tract disorder and unable to eat. The action taken with Aspirin was unknown. The action taken with naproxen was unknown. On an unknown date, the outcome of the gastric irritation, stomach burning sensation of and unable to eat were unknown and the outcome of the stomach pain, chills, sweating, dry heaves, nausea and urinary tract disorder were recovered/resolved.   It was unknown if the reporter considered the gastric irritation, stomach pain, stomach burning sensation of, chills, sweating, dry heaves, nausea, urinary tract disorder and unable to eat to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient volunteers that she has an unknown problem with her esophagus and underwent a stomach wrap procedure several years ago. The patient received 2nd dose of Shingrix on left arm. One or two days after receiving 2nd dose of Shingrix, the patient experienced stomach pain and burning, chills, sweating, nausea, dry heaves and inability to eat or drink. The patient also experienced a sensation that she had to urinate all the time. The patient experienced a similar reaction following the first Pfizer COVID-19 vaccine (date of administration unknown). On 2nd June 2021, the patient underwent an endoscopy that showed mild irritation that may be related to use of Aspirin, Naproxen, NSAIDs, or alcohol and reflux. It was unknown if the reporter considered the gastric irritation, stomach pain, stomach burning sensation of, chills, sweating, dry heaves, nausea, urinary tract disorder and unable to eat to be related to Covid-19 vaccine Pfizer. The reporter considered the gastric irritation, stomach pain, stomach burning sensation of, chills, sweating, dry heaves, nausea, urinary tract disorder and unable to eat to be related to Naproxen and NSAIDs or alcohol and reflux. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021131455:Same reporter